Delivery Order SPE2DR25D3301-SPE2DR26F19WR
Award Date 12/23/25
Potential Completion Date 12/24/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Fycompa 0.5 mg/ml oral suspension in a 340ml quantity, valued at $10,227.18. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency (DLA) awarded a $1,930.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fycompa 0.5 mg/mL oral suspension (340mL) on December 16, 2025, with completion targeted for December 17, 2025. This non-competitive delivery order represents a small-value pharmaceutical procurement executed from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order valued at $7,307.89 to AmerisourceBergen Drug Corp for Fycompa 0.5 mg/ml oral suspension (340ml) on July 18, 2025. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, with performance to occur at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for Fycompa 8 mg tablets (30-count units) with a ceiling value of $1,713.96. This firm fixed-price delivery order, which is expected to be completed by June 4, 2025, represents a continuation of AmerisourceBergen's significant role as a pharmaceutical supplier to the federal government. The award was made without a set-aside designation, indicating open competition. The performance location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fycompa 12 mg tablets (30-count) with a ceiling value of $1,018.26. This competitively awarded, firm fixed-price delivery order was placed on December 10, 2025, with an ultimate completion date of December 11, 2025. The contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fycompa 4 mg tablets (30-count units) on November 7, 2025, with a contract ceiling value of $3,186.63 and completion date of November 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single line item fulfillment under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a $2,868.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 340 mL of Fycompa 0.5 mg/mL oral suspension, with an ultimate completion date of December 24, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be performed and delivered from the contractor's Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,806.92 to AmerisourceBergen Drug Corp for FYCOMPA 0.5 mg/ml oral suspension (340ml) on October 28, 2025, with completion expected by October 29, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award for pharmaceutical supply. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.14 to AmerisourceBergen Drug Corp for Fycompa 10 mg tablets (30-count package) on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price delivery order represents a non-competitive award executed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,580.41 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fycompa 8 mg tablets (30-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's place of performance. This...